Rockwell Medical, Inc.
RMTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001041024
In the last 90 days, Rockwell Medical, Inc. insiders filed 0 open-market purchases and 1 sale; 37 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $29.5M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $8.42K in total
- 1
- 13F holdersQ2 2026, −5 vs. previous quarter
- 37
- 13F valueReported value at the end of Q2 2026
- $1.90M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $69.3M
- −31.8% year over year
- Net income, FY2025
- -$5.31M
- No comparable prior period
- Free cash flow, FY2025
- -$1.20M
- −137.6% year over year
- Revenue, Q2 FY2026
- $17.8M
- +10.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $5.31M (7.7% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 35.5K
- Shares sold short
- Change
- −34.5K
- −49.3% vs. previous
- Days to cover
- 1.44
- At average daily volume
Superinvestors holding RMTI, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding RMTI at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Rockwell Medical, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 (view filing)4:03 PM ET | Oct 1 | 4 days | Strobeck MarkPresident and CEO | SSale | −1.00K | $8.42 | −$8.42K | −1.6%61.3K after | 10b5-1 |
| Jan 5, 2026 (view filing) | Jan 2 | 3 days | Hunter HeatherChief Operating Officer | SSale | −2.87K | $0.84 | −$2.41K | −2.1%132.5K after | 10b5-1 |
| Jan 5, 2026 (view filing) | Jan 2 | 3 days | Neri JesseSVP and CFO | SSale | −886 | $0.84 | −$744.24 | −0.7%124.8K after | 10b5-1 |
| Nov 18, 2025 (view filing) | Nov 18 | Same day | Cooper John GDirector | SSale | −5.08K | $0.87 | −$4.42K | −3.5%140.4K after | |
| Oct 8, 2025 (view filing) | Oct 1 | 7 daysLate | Hunter HeatherSVP, Chief Operating Officer | SSale | −2.87K | $1.19 | −$3.41K | −2.1%135.4K after | 10b5-1 |
| Oct 1, 2025 (view filing) | Oct 1 | Same day | Chole TimothySVP and CCO | SSale | −2.87K | $1.19 | −$3.41K | −2.2%125.3K after | 10b5-1 |
| Oct 1, 2025 (view filing) | Oct 1 | Same day | Neri JesseSVP and CFO | SSale | −886 | $1.19 | −$1.05K | −0.7%125.7K after | 10b5-1 |
| Oct 1, 2025 (view filing) | Oct 1 | Same day | Strobeck MarkPresident and CEO | SSale | −6.93K | $1.19 | −$8.24K | −2.1%330.8K after | 10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Chole TimothySVP and CCO | SSale | −2.87K | $0.82 | −$2.35K | −2.2%128.2K after | Amended10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Strobeck MarkPresident and CEO | SSale | −6.93K | $0.82 | −$5.68K | −2.0%337.8K after | Amended10b5-1 |
Top 10 13F holders, Q2 2026
See all 37 holdersThe largest institutional positions in Rockwell Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,229,888 | $677.7K | 0.00% | +47,527+4.0% | Added |
| Geode Capital Management, LLC | 364,061 | $213.9K | 0.00% | −65,119−15.2% | Reduced |
| Renaissance Technologies LLC | 359,672 | $198.0K | 0.00% | −279,448−43.7% | Reduced |
| Jane Street Group, LLC | 245,229 | $135.0K | 0.00% | +166,273+210.6% | Added |
| Vanguard Fiduciary Trust Co | 232,660 | $128.2K | 0.00% | +1,402+0.6% | Added |
| Wealthspire Advisors, LLC | 151,838 | $83.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 144,756 | $79.7K | 0.00% | −91,915−38.8% | Reduced |
| State Street Corp | 100,904 | $55.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 91,862 | $50.6K | 0.00% | −12,661−12.1% | Reduced |
| UBS Group AG | 70,010 | $38.5K | 0.00% | −108,876−60.9% | Reduced |
Holders of 5% or more of RMTI
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Rockwell Medical, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Irrevocable Larson Family Investment Trust | 13G/A | 10.70%3.47M shares | +0.80 ppfrom 9.90% | May 3, 202411 filings | Dec 17, 2024 | SEC |